Page last updated: 2024-08-21

thymoquinone and gemcitabine

thymoquinone has been researched along with gemcitabine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banerjee, S; Kaseb, AO; Kong, D; Mohammad, M; Mohammad, RM; Padhye, S; Sarkar, FH; Wang, Z1
Azmi, AS; Banerjee, S; Baruah, JB; Mohammad, RM; Padhye, S; Philip, PA; Sarkar, FH; Singh, MW1
Bamezai, RN; Kumar, B; Manvati, S; Pandita, A; Singh, SK; Vaishnavi, S1
Li, HY; Liao, Y; Mu, GG; Yu, HG; Zhang, LL1
Bamezai, RN; Manvati, S; Pandita, A; Singh, SK; Vaishnavi, S1

Other Studies

5 other study(ies) available for thymoquinone and gemcitabine

ArticleYear
Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cancer.
    Cancer research, 2009, Jul-01, Volume: 69, Issue:13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cytochromes c; Deoxycytidine; Dinoprostone; Drug Synergism; Female; Gemcitabine; Humans; Mice; Mice, Inbred ICR; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms

2009
Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer.
    Pharmaceutical research, 2010, Volume: 27, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoquinones; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclooxygenase 1; Cyclooxygenase 2; Deoxycytidine; Gemcitabine; Humans; Mice; Mice, SCID; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Prostaglandins E; Structure-Activity Relationship

2010
Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Benzoquinones; Betulinic Acid; Carrier Proteins; Cell Proliferation; Deoxycytidine; Drug Synergism; Flow Cytometry; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunoblotting; Membrane Potential, Mitochondrial; Membrane Proteins; Pancreatic Neoplasms; Pentacyclic Triterpenes; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Triterpenes; Tumor Cells, Cultured

2014
Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:4

    Topics: Animals; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Mice, Inbred BALB C; Mice, Nude; Nigella sativa; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-akt; Receptor, Notch1; Signal Transduction; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2015
Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines.
    Chemico-biological interactions, 2015, May-25, Volume: 233

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Benzoquinones; Betulinic Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dietary Supplements; Drug Synergism; Gemcitabine; Humans; MicroRNAs; Pancreas; Pancreatic Neoplasms; Pentacyclic Triterpenes; Transfection; Triterpenes

2015